学习经历

2020.09-2024.06，大连理工大学，生物工程，博士；

2017.09-2020.06，大连理工大学，生物工程，硕士；

2013.09-2017.06，信阳师范大学，化学工程与工艺，学士。

工作经历

2024.06-至今，阜阳师范大学，讲师。

研究方向

(1) 天然活性成分的筛选及成药性评价

(2) 皖北特色植物太和香椿、桔梗等的开发利用

(3) 药物代谢动力学

(4) 药物毒理学

代表性研究成果

1. Wang Z, Jiang L, Lv X, Yin H, Wang Z, Li W, Liu Y. Higher risk of hepatotoxicity associated with cabozantinib in cancer patients. Critical Reviews in Oncology/Hematology. 2024 Feb 15; 196:104298.

2. Wang Z, Wang Z, Wang X, Lv X, Yin H, Jiang L, Xia Y, Li W, Li W, Liu Y. Potential food-drug interaction risk of thymoquinone with warfarin. Chemico-Biological Interactions. 2022 Sep 25; 365:110070.

3. Wang Z, Wang Z, Wang X, Lv X, Yin H, Fan X, Yan M, Jia Y, Jiang L, Xia Y, Li W, Liu Y. In vitro effects of opicapone on activity of human UDP-glucuronosyltransferases isoforms. Toxicology Letters. 2022 Aug 15; 367:3-8.

4. Li W#, Wang Z#, Wang X, Cao X, Bi C, Jiang L, Cui S, Liu Y. Risk prediction of drug-drug interaction potential of phenytoin and miconazole topical formulations. Chemico-Biological Interactions. 2021 Jul 1; 343:109498.

5. Wang Z, Wang X, Wang Z, Feng Y, Jia Y, Jiang L, Xia Y, Cao J, Liu Y. Comparison of Hepatotoxicity Associated with New BCR-ABL Tyrosine Kinase Inhibitors vs Imatinib Among Patients with Chronic Myeloid Leukemia: A Systematic Review and Meta-analysis. JAMA Network Open. 2021 Jul 1;4(7):e2120165. (SCI, JCR1区)

6. Jiang L, Wang Z, Wang X, Wang S, Cao J, Liu Y. Exploring the inhibitory mechanism of piceatannol on α-glucosidase relevant to diabetes mellitus. RSC Advances. 2020 Jan 29;10(8):4529-4537.